share_log

BioNTech | 6-K: BioNTech to Present Clinical Data Updates For Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024

BioNTech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

BioNTech | 6-K:外国发行人报告
美股SEC公告 ·  03/11 09:06
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息